Summary
IDEXX Laboratories, Inc. (IDXX) has filed an 8-K report on October 31, 2024, to announce its financial results for the third quarter ended September 30, 2024. The report primarily serves to furnish the company's earnings press release, which contains the detailed financial performance and operational updates for the period. Investors should refer to Exhibit 99.1 for the complete earnings announcement. This filing does not contain new financial statements or significant operational changes beyond what is disclosed in the accompanying press release. The information furnished is for informational purposes and is not deemed "filed" for purposes of Section 18 of the Exchange Act, unless specifically incorporated by reference into other filings. The Chief Financial Officer, Brian P. McKeon, signed the report.
Key Highlights
- 1IDEXX Laboratories announced its third quarter financial results for the period ending September 30, 2024.
- 2The full financial results and operational details are provided in the press release furnished as Exhibit 99.1.
- 3The filing is an 8-K dated October 31, 2024.
- 4The information is furnished under Item 2.02 (Results of Operations and Financial Condition).
- 5The company has elected not to use the extended transition period for new or revised financial accounting standards.
- 6Exhibit 99.1 contains the press release titled 'IDEXX Laboratories Announces Third Quarter Results'.
- 7The report is signed by Brian P. McKeon, Executive Vice President, Chief Financial Officer and Treasurer.